ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cold Sore Antiviral Drug Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-36H14013
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Cold Sore Antiviral Drug Market Research Report 2023
BUY CHAPTERS

Global Cold Sore Antiviral Drug Market Research Report 2025

Code: QYRE-Auto-36H14013
Report
April 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ortho Dermatologics
Foundation Consumer Healthcare
Novartis
Teva Pharmaceuticals
Amneal Pharmaceuticals LLC
AiCuris
Apotex
Aurobindo Pharma USA Inc.
Cipla Ltd
Glenmark Pharmaceuticals, Inc.
Hikma Pharmaceuticals
HRA Pharma
Hetero Healthcare Ltd
Jubilant Cadista
Merix Pharmaceutical Corp
Sun Pharmaceutical Industries Ltd.
Viatris
WOCKHARDT
Zydus Pharmaceuticals
GlaxoSmithKline PLC

Cold Sore Antiviral Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cold Sore Antiviral Drug Market

Cold Sore Antiviral Drug Market

The global market for Cold Sore Antiviral Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cold Sore Antiviral Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold Sore Antiviral Drug.
The Cold Sore Antiviral Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cold Sore Antiviral Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cold Sore Antiviral Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cold Sore Antiviral Drug Market Report

Report Metric Details
Report Name Cold Sore Antiviral Drug Market
CAGR 5%
Segment by Type
  • Smear
  • Oral
  • Others
Segment by Application
  • Child
  • Aldult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Ortho Dermatologics, Foundation Consumer Healthcare, Novartis, Teva Pharmaceuticals, Amneal Pharmaceuticals LLC, AiCuris, Apotex, Aurobindo Pharma USA, Inc., Cipla, Glenmark Pharmaceuticals, Inc., Hikma Pharmaceuticals, HRA Pharma, Hetero Healthcare Ltd, Jubilant Cadista, Merix Pharmaceutical Corp, Sun Pharmaceutical Industries Ltd., Viatris, Wockhardt, Zydus Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cold Sore Antiviral Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cold Sore Antiviral Drug Market report?

Ans: The main players in the Cold Sore Antiviral Drug Market are GlaxoSmithKline, Ortho Dermatologics, Foundation Consumer Healthcare, Novartis, Teva Pharmaceuticals, Amneal Pharmaceuticals LLC, AiCuris, Apotex, Aurobindo Pharma USA, Inc., Cipla, Glenmark Pharmaceuticals, Inc., Hikma Pharmaceuticals, HRA Pharma, Hetero Healthcare Ltd, Jubilant Cadista, Merix Pharmaceutical Corp, Sun Pharmaceutical Industries Ltd., Viatris, Wockhardt, Zydus Pharmaceuticals

What are the Application segmentation covered in the Cold Sore Antiviral Drug Market report?

Ans: The Applications covered in the Cold Sore Antiviral Drug Market report are Child, Aldult

What are the Type segmentation covered in the Cold Sore Antiviral Drug Market report?

Ans: The Types covered in the Cold Sore Antiviral Drug Market report are Smear, Oral, Others

Recommended Reports

Antiviral Drug Markets

Herpes And Cold Sores

Infectious Disease Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Sore Antiviral Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Smear
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cold Sore Antiviral Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Child
1.3.3 Aldult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cold Sore Antiviral Drug Market Perspective (2020-2031)
2.2 Global Cold Sore Antiviral Drug Growth Trends by Region
2.2.1 Global Cold Sore Antiviral Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cold Sore Antiviral Drug Historic Market Size by Region (2020-2025)
2.2.3 Cold Sore Antiviral Drug Forecasted Market Size by Region (2026-2031)
2.3 Cold Sore Antiviral Drug Market Dynamics
2.3.1 Cold Sore Antiviral Drug Industry Trends
2.3.2 Cold Sore Antiviral Drug Market Drivers
2.3.3 Cold Sore Antiviral Drug Market Challenges
2.3.4 Cold Sore Antiviral Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Sore Antiviral Drug Players by Revenue
3.1.1 Global Top Cold Sore Antiviral Drug Players by Revenue (2020-2025)
3.1.2 Global Cold Sore Antiviral Drug Revenue Market Share by Players (2020-2025)
3.2 Global Cold Sore Antiviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cold Sore Antiviral Drug Revenue
3.4 Global Cold Sore Antiviral Drug Market Concentration Ratio
3.4.1 Global Cold Sore Antiviral Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Sore Antiviral Drug Revenue in 2024
3.5 Global Key Players of Cold Sore Antiviral Drug Head office and Area Served
3.6 Global Key Players of Cold Sore Antiviral Drug, Product and Application
3.7 Global Key Players of Cold Sore Antiviral Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold Sore Antiviral Drug Breakdown Data by Type
4.1 Global Cold Sore Antiviral Drug Historic Market Size by Type (2020-2025)
4.2 Global Cold Sore Antiviral Drug Forecasted Market Size by Type (2026-2031)
5 Cold Sore Antiviral Drug Breakdown Data by Application
5.1 Global Cold Sore Antiviral Drug Historic Market Size by Application (2020-2025)
5.2 Global Cold Sore Antiviral Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cold Sore Antiviral Drug Market Size (2020-2031)
6.2 North America Cold Sore Antiviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cold Sore Antiviral Drug Market Size by Country (2020-2025)
6.4 North America Cold Sore Antiviral Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cold Sore Antiviral Drug Market Size (2020-2031)
7.2 Europe Cold Sore Antiviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cold Sore Antiviral Drug Market Size by Country (2020-2025)
7.4 Europe Cold Sore Antiviral Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold Sore Antiviral Drug Market Size (2020-2031)
8.2 Asia-Pacific Cold Sore Antiviral Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cold Sore Antiviral Drug Market Size (2020-2031)
9.2 Latin America Cold Sore Antiviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cold Sore Antiviral Drug Market Size by Country (2020-2025)
9.4 Latin America Cold Sore Antiviral Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Sore Antiviral Drug Market Size (2020-2031)
10.2 Middle East & Africa Cold Sore Antiviral Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Cold Sore Antiviral Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Ortho Dermatologics
11.2.1 Ortho Dermatologics Company Details
11.2.2 Ortho Dermatologics Business Overview
11.2.3 Ortho Dermatologics Cold Sore Antiviral Drug Introduction
11.2.4 Ortho Dermatologics Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.2.5 Ortho Dermatologics Recent Development
11.3 Foundation Consumer Healthcare
11.3.1 Foundation Consumer Healthcare Company Details
11.3.2 Foundation Consumer Healthcare Business Overview
11.3.3 Foundation Consumer Healthcare Cold Sore Antiviral Drug Introduction
11.3.4 Foundation Consumer Healthcare Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.3.5 Foundation Consumer Healthcare Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cold Sore Antiviral Drug Introduction
11.4.4 Novartis Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.5.4 Teva Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Amneal Pharmaceuticals LLC
11.6.1 Amneal Pharmaceuticals LLC Company Details
11.6.2 Amneal Pharmaceuticals LLC Business Overview
11.6.3 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Introduction
11.6.4 Amneal Pharmaceuticals LLC Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.6.5 Amneal Pharmaceuticals LLC Recent Development
11.7 AiCuris
11.7.1 AiCuris Company Details
11.7.2 AiCuris Business Overview
11.7.3 AiCuris Cold Sore Antiviral Drug Introduction
11.7.4 AiCuris Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.7.5 AiCuris Recent Development
11.8 Apotex
11.8.1 Apotex Company Details
11.8.2 Apotex Business Overview
11.8.3 Apotex Cold Sore Antiviral Drug Introduction
11.8.4 Apotex Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.8.5 Apotex Recent Development
11.9 Aurobindo Pharma USA, Inc.
11.9.1 Aurobindo Pharma USA, Inc. Company Details
11.9.2 Aurobindo Pharma USA, Inc. Business Overview
11.9.3 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Introduction
11.9.4 Aurobindo Pharma USA, Inc. Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.9.5 Aurobindo Pharma USA, Inc. Recent Development
11.10 Cipla
11.10.1 Cipla Company Details
11.10.2 Cipla Business Overview
11.10.3 Cipla Cold Sore Antiviral Drug Introduction
11.10.4 Cipla Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.10.5 Cipla Recent Development
11.11 Glenmark Pharmaceuticals, Inc.
11.11.1 Glenmark Pharmaceuticals, Inc. Company Details
11.11.2 Glenmark Pharmaceuticals, Inc. Business Overview
11.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Introduction
11.11.4 Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.11.5 Glenmark Pharmaceuticals, Inc. Recent Development
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Details
11.12.2 Hikma Pharmaceuticals Business Overview
11.12.3 Hikma Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.12.4 Hikma Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.12.5 Hikma Pharmaceuticals Recent Development
11.13 HRA Pharma
11.13.1 HRA Pharma Company Details
11.13.2 HRA Pharma Business Overview
11.13.3 HRA Pharma Cold Sore Antiviral Drug Introduction
11.13.4 HRA Pharma Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.13.5 HRA Pharma Recent Development
11.14 Hetero Healthcare Ltd
11.14.1 Hetero Healthcare Ltd Company Details
11.14.2 Hetero Healthcare Ltd Business Overview
11.14.3 Hetero Healthcare Ltd Cold Sore Antiviral Drug Introduction
11.14.4 Hetero Healthcare Ltd Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.14.5 Hetero Healthcare Ltd Recent Development
11.15 Jubilant Cadista
11.15.1 Jubilant Cadista Company Details
11.15.2 Jubilant Cadista Business Overview
11.15.3 Jubilant Cadista Cold Sore Antiviral Drug Introduction
11.15.4 Jubilant Cadista Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.15.5 Jubilant Cadista Recent Development
11.16 Merix Pharmaceutical Corp
11.16.1 Merix Pharmaceutical Corp Company Details
11.16.2 Merix Pharmaceutical Corp Business Overview
11.16.3 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Introduction
11.16.4 Merix Pharmaceutical Corp Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.16.5 Merix Pharmaceutical Corp Recent Development
11.17 Sun Pharmaceutical Industries Ltd.
11.17.1 Sun Pharmaceutical Industries Ltd. Company Details
11.17.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.17.3 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Introduction
11.17.4 Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.17.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.18 Viatris
11.18.1 Viatris Company Details
11.18.2 Viatris Business Overview
11.18.3 Viatris Cold Sore Antiviral Drug Introduction
11.18.4 Viatris Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.18.5 Viatris Recent Development
11.19 Wockhardt
11.19.1 Wockhardt Company Details
11.19.2 Wockhardt Business Overview
11.19.3 Wockhardt Cold Sore Antiviral Drug Introduction
11.19.4 Wockhardt Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.19.5 Wockhardt Recent Development
11.20 Zydus Pharmaceuticals
11.20.1 Zydus Pharmaceuticals Company Details
11.20.2 Zydus Pharmaceuticals Business Overview
11.20.3 Zydus Pharmaceuticals Cold Sore Antiviral Drug Introduction
11.20.4 Zydus Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025)
11.20.5 Zydus Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Ortho Dermatologics
Foundation Consumer Healthcare
Novartis
Teva Pharmaceuticals
Amneal Pharmaceuticals LLC
AiCuris
Apotex
Aurobindo Pharma USA Inc.
Cipla Ltd
Glenmark Pharmaceuticals, Inc.
Hikma Pharmaceuticals
HRA Pharma
Hetero Healthcare Ltd
Jubilant Cadista
Merix Pharmaceutical Corp
Sun Pharmaceutical Industries Ltd.
Viatris
WOCKHARDT
Zydus Pharmaceuticals
GlaxoSmithKline PLC
List of Tables
 Table 1. Global Cold Sore Antiviral Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Smear
 Table 3. Key Players of Oral
 Table 4. Key Players of Others
 Table 5. Global Cold Sore Antiviral Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cold Sore Antiviral Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cold Sore Antiviral Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cold Sore Antiviral Drug Market Share by Region (2020-2025)
 Table 9. Global Cold Sore Antiviral Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cold Sore Antiviral Drug Market Share by Region (2026-2031)
 Table 11. Cold Sore Antiviral Drug Market Trends
 Table 12. Cold Sore Antiviral Drug Market Drivers
 Table 13. Cold Sore Antiviral Drug Market Challenges
 Table 14. Cold Sore Antiviral Drug Market Restraints
 Table 15. Global Cold Sore Antiviral Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cold Sore Antiviral Drug Market Share by Players (2020-2025)
 Table 17. Global Top Cold Sore Antiviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2024)
 Table 18. Ranking of Global Top Cold Sore Antiviral Drug Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cold Sore Antiviral Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cold Sore Antiviral Drug, Headquarters and Area Served
 Table 21. Global Key Players of Cold Sore Antiviral Drug, Product and Application
 Table 22. Global Key Players of Cold Sore Antiviral Drug, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cold Sore Antiviral Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cold Sore Antiviral Drug Revenue Market Share by Type (2020-2025)
 Table 26. Global Cold Sore Antiviral Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cold Sore Antiviral Drug Revenue Market Share by Type (2026-2031)
 Table 28. Global Cold Sore Antiviral Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cold Sore Antiviral Drug Revenue Market Share by Application (2020-2025)
 Table 30. Global Cold Sore Antiviral Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cold Sore Antiviral Drug Revenue Market Share by Application (2026-2031)
 Table 32. North America Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cold Sore Antiviral Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cold Sore Antiviral Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cold Sore Antiviral Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cold Sore Antiviral Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cold Sore Antiviral Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cold Sore Antiviral Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cold Sore Antiviral Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 47. GlaxoSmithKline Company Details
 Table 48. GlaxoSmithKline Business Overview
 Table 49. GlaxoSmithKline Cold Sore Antiviral Drug Product
 Table 50. GlaxoSmithKline Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 51. GlaxoSmithKline Recent Development
 Table 52. Ortho Dermatologics Company Details
 Table 53. Ortho Dermatologics Business Overview
 Table 54. Ortho Dermatologics Cold Sore Antiviral Drug Product
 Table 55. Ortho Dermatologics Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 56. Ortho Dermatologics Recent Development
 Table 57. Foundation Consumer Healthcare Company Details
 Table 58. Foundation Consumer Healthcare Business Overview
 Table 59. Foundation Consumer Healthcare Cold Sore Antiviral Drug Product
 Table 60. Foundation Consumer Healthcare Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 61. Foundation Consumer Healthcare Recent Development
 Table 62. Novartis Company Details
 Table 63. Novartis Business Overview
 Table 64. Novartis Cold Sore Antiviral Drug Product
 Table 65. Novartis Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 66. Novartis Recent Development
 Table 67. Teva Pharmaceuticals Company Details
 Table 68. Teva Pharmaceuticals Business Overview
 Table 69. Teva Pharmaceuticals Cold Sore Antiviral Drug Product
 Table 70. Teva Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 71. Teva Pharmaceuticals Recent Development
 Table 72. Amneal Pharmaceuticals LLC Company Details
 Table 73. Amneal Pharmaceuticals LLC Business Overview
 Table 74. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product
 Table 75. Amneal Pharmaceuticals LLC Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 76. Amneal Pharmaceuticals LLC Recent Development
 Table 77. AiCuris Company Details
 Table 78. AiCuris Business Overview
 Table 79. AiCuris Cold Sore Antiviral Drug Product
 Table 80. AiCuris Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 81. AiCuris Recent Development
 Table 82. Apotex Company Details
 Table 83. Apotex Business Overview
 Table 84. Apotex Cold Sore Antiviral Drug Product
 Table 85. Apotex Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 86. Apotex Recent Development
 Table 87. Aurobindo Pharma USA, Inc. Company Details
 Table 88. Aurobindo Pharma USA, Inc. Business Overview
 Table 89. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product
 Table 90. Aurobindo Pharma USA, Inc. Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 91. Aurobindo Pharma USA, Inc. Recent Development
 Table 92. Cipla Company Details
 Table 93. Cipla Business Overview
 Table 94. Cipla Cold Sore Antiviral Drug Product
 Table 95. Cipla Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 96. Cipla Recent Development
 Table 97. Glenmark Pharmaceuticals, Inc. Company Details
 Table 98. Glenmark Pharmaceuticals, Inc. Business Overview
 Table 99. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product
 Table 100. Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 101. Glenmark Pharmaceuticals, Inc. Recent Development
 Table 102. Hikma Pharmaceuticals Company Details
 Table 103. Hikma Pharmaceuticals Business Overview
 Table 104. Hikma Pharmaceuticals Cold Sore Antiviral Drug Product
 Table 105. Hikma Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 106. Hikma Pharmaceuticals Recent Development
 Table 107. HRA Pharma Company Details
 Table 108. HRA Pharma Business Overview
 Table 109. HRA Pharma Cold Sore Antiviral Drug Product
 Table 110. HRA Pharma Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 111. HRA Pharma Recent Development
 Table 112. Hetero Healthcare Ltd Company Details
 Table 113. Hetero Healthcare Ltd Business Overview
 Table 114. Hetero Healthcare Ltd Cold Sore Antiviral Drug Product
 Table 115. Hetero Healthcare Ltd Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 116. Hetero Healthcare Ltd Recent Development
 Table 117. Jubilant Cadista Company Details
 Table 118. Jubilant Cadista Business Overview
 Table 119. Jubilant Cadista Cold Sore Antiviral Drug Product
 Table 120. Jubilant Cadista Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 121. Jubilant Cadista Recent Development
 Table 122. Merix Pharmaceutical Corp Company Details
 Table 123. Merix Pharmaceutical Corp Business Overview
 Table 124. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product
 Table 125. Merix Pharmaceutical Corp Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 126. Merix Pharmaceutical Corp Recent Development
 Table 127. Sun Pharmaceutical Industries Ltd. Company Details
 Table 128. Sun Pharmaceutical Industries Ltd. Business Overview
 Table 129. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product
 Table 130. Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 131. Sun Pharmaceutical Industries Ltd. Recent Development
 Table 132. Viatris Company Details
 Table 133. Viatris Business Overview
 Table 134. Viatris Cold Sore Antiviral Drug Product
 Table 135. Viatris Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 136. Viatris Recent Development
 Table 137. Wockhardt Company Details
 Table 138. Wockhardt Business Overview
 Table 139. Wockhardt Cold Sore Antiviral Drug Product
 Table 140. Wockhardt Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 141. Wockhardt Recent Development
 Table 142. Zydus Pharmaceuticals Company Details
 Table 143. Zydus Pharmaceuticals Business Overview
 Table 144. Zydus Pharmaceuticals Cold Sore Antiviral Drug Product
 Table 145. Zydus Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2020-2025) & (US$ Million)
 Table 146. Zydus Pharmaceuticals Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. Cold Sore Antiviral Drug Picture
 Figure 2. Global Cold Sore Antiviral Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cold Sore Antiviral Drug Market Share by Type: 2024 VS 2031
 Figure 4. Smear Features
 Figure 5. Oral Features
 Figure 6. Others Features
 Figure 7. Global Cold Sore Antiviral Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cold Sore Antiviral Drug Market Share by Application: 2024 VS 2031
 Figure 9. Child Case Studies
 Figure 10. Aldult Case Studies
 Figure 11. Cold Sore Antiviral Drug Report Years Considered
 Figure 12. Global Cold Sore Antiviral Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Cold Sore Antiviral Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cold Sore Antiviral Drug Market Share by Region: 2024 VS 2031
 Figure 15. Global Cold Sore Antiviral Drug Market Share by Players in 2024
 Figure 16. Global Top Cold Sore Antiviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Cold Sore Antiviral Drug Revenue in 2024
 Figure 18. North America Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Cold Sore Antiviral Drug Market Share by Country (2020-2031)
 Figure 20. United States Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cold Sore Antiviral Drug Market Share by Country (2020-2031)
 Figure 24. Germany Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cold Sore Antiviral Drug Market Share by Region (2020-2031)
 Figure 32. China Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cold Sore Antiviral Drug Market Share by Country (2020-2031)
 Figure 40. Mexico Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cold Sore Antiviral Drug Market Share by Country (2020-2031)
 Figure 44. Turkey Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Cold Sore Antiviral Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. GlaxoSmithKline Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 48. Ortho Dermatologics Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 49. Foundation Consumer Healthcare Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 52. Amneal Pharmaceuticals LLC Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 53. AiCuris Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 54. Apotex Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 55. Aurobindo Pharma USA, Inc. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 56. Cipla Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 57. Glenmark Pharmaceuticals, Inc. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 58. Hikma Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 59. HRA Pharma Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 60. Hetero Healthcare Ltd Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 61. Jubilant Cadista Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 62. Merix Pharmaceutical Corp Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 63. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 64. Viatris Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 65. Wockhardt Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 66. Zydus Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Cold Sore Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Antiviral Drugs Market
Direct acting Antiviral Drugs Market
Respiratory Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antiviral Medicine Market Research Report 2025
Specific Antiviral Drugs for COVID 19 Market
Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti infectious Disease Drugs Market Research Report 2025
Global Cold Cough and Sore Throat Remedies Market Research Report 2024
Global Respiratory Antiviral Treatment Market Research Report 2024
Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Virus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024
Global Anti Retroviral Drugs Market Research Report 2024
Global Herpes Infection Treatment Market Research Report 2025
HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions